Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Biocept Inc (BIOCQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.001 0.000    0.00%
23/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.000 - 0.001
Biocept 0.001 0.000 0.00%

Biocept Inc Company Profile

 
Get an in-depth profile of Biocept Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

50

Equity Type

ORD

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Contact Information

Address 9955 Mesa Rim Road
San Diego, 92121
United States
Phone 858 320 8200
Fax 858 320 8225

Top Executives

Name Age Since Title
Fred R. Hirsch - - Member of Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIOCQ Comments

Write your thoughts about Biocept Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mary Hill
Mary Hill Nov 23, 2023 4:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow 5 cent 😳
Lotiful Islam babu
Lotiful Islam babu Oct 20, 2023 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will be 0.10
Fardad Gharibi
Fardad Gharibi May 23, 2023 9:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon will be +10 $
Joeri Houbrechts
Joeri Houbrechts Jul 08, 2022 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The only way is up
paola bastoni
paola bastoni Feb 18, 2022 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Record revenue expected
Josep Magrans Llop
Josep Magrans Llop Jan 22, 2022 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.proactiveinvestors.com/companies/news/971834/biocept-says-demand-for-its-covid-19-rt-pcr-testing-increases-in-2022-amid-omicron-variant-surge-971834.html
Josep Magrans Llop
Josep Magrans Llop Jan 22, 2022 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Biocept dice que la demanda de sus pruebas COVID-19 RT-PCR aumenta en 2022 en medio del aumento de variantes de OmicronBiocept continúa sirviendo a la comunidad con pruebas de alta calidad, habiendo recibido más de 40,000 muestras para pruebas de COVID-19 desde principios de 2022
Josep Magrans Llop
Josep Magrans Llop Dec 01, 2021 9:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.prnewswire.com/news-releases/quest-diagnostics-now-offers-biocepts-liquid-biopsy-test-for-lung-cancer-expanding-its-menu-of-advanced-cancer-diagnostics-301435081.html
Josep Magrans Llop
Josep Magrans Llop Oct 07, 2021 11:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.nasdaq.com/articles/7-of-the-best-penny-stocks-to-buy-coming-into-year-end-2021-09-21
Josep Magrans Llop
Josep Magrans Llop Oct 06, 2021 5:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PROJECTION UNTIL  13$  https://invst.ly/w88nk
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email